Abstract:Accurately predicting molecular properties is a challenging but essential task in drug discovery. Recently, many mono-modal deep learning methods have been successfully applied to molecular property prediction. However, mono-modal learning is inherently limited as it relies solely on a single modality of molecular representation, which restricts a comprehensive understanding of drug molecules. To overcome the limitations, we propose a multimodal fused deep learning (MMFDL) model to leverage information from different molecular representations. Specifically, we construct a triple-modal learning model by employing Transformer-Encoder, Bidirectional Gated Recurrent Unit (BiGRU), and graph convolutional network (GCN) to process three modalities of information from chemical language and molecular graph: SMILES-encoded vectors, ECFP fingerprints, and molecular graphs, respectively. We evaluate the proposed triple-modal model using five fusion approaches on six molecule datasets, including Delaney, Llinas2020, Lipophilicity, SAMPL, BACE, and pKa from DataWarrior. The results show that the MMFDL model achieves the highest Pearson coefficients, and stable distribution of Pearson coefficients in the random splitting test, outperforming mono-modal models in accuracy and reliability. Furthermore, we validate the generalization ability of our model in the prediction of binding constants for protein-ligand complex molecules, and assess the resilience capability against noise. Through analysis of feature distributions in chemical space and the assigned contribution of each modal model, we demonstrate that the MMFDL model shows the ability to acquire complementary information by using proper models and suitable fusion approaches. By leveraging diverse sources of bioinformatics information, multimodal deep learning models hold the potential for successful drug discovery.

Multiple Instance Learning of Real Valued Data

Feasibility of Active Machine Learning for Multiclass Compound Classification

Current Methods for Drug Property Prediction in the Real World

miDruglikeness: Subdivisional Drug-likeness Prediction Models Using Active Ensemble Learning Strategies

Current Trends and Challenges in Drug-Likeness Prediction: Are They Generalizable and Interpretable?

DeepREAL: A Deep Learning Powered Multi-scale Modeling Framework Towards Predicting Out-of-distribution Receptor Activity of Ligand Binding

Neural Networks for Multi-Instance Learning

A review of multi-instance learning assumptions

DrugMetric: quantitative drug-likeness scoring based on chemical space distance

A Novel Descriptor and Molecular Graph-Based Bimodal Contrastive Learning Framework for Drug Molecular Property Prediction.

Deep Multiple Instance Learning on Heterogeneous Graph for Drug-Disease Association Prediction.

Modeling DTA by Combining Multiple-Instance Learning with a Private-Public Mechanism

Novel Big Data-Driven Machine Learning Models for Drug Discovery Application

A Flexible and Robust Multi-Source Learning Algorithm for Drug Repositioning

Deep learning of multimodal networks with topological regularization for drug repositioning

Dynamic Interaction Learning and Multimodal Representation for Drug Response Prediction

Machine Learning Small Molecule Properties in Drug Discovery

MultiCon: A Semi-Supervised Approach for Predicting Drug Function from Chemical Structure Analysis

A general hypergraph learning algorithm for drug multi-task predictions in micro-to-macro biomedical networks

DeepREAL: a deep learning powered multi-scale modeling framework for predicting out-of-distribution ligand-induced GPCR activity

Multimodal fused deep learning for drug property prediction: Integrating chemical language and molecular graph